Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.30 |
| ▸ | HPGDS | O60760 | 1/20 | 0.30 |
| ▸ | SPR | P35270 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3618691 | 0.75 | NR5A2 (0.38) | TP53MAPTSMN1; SMN2HDAC2ALOX5 | |
| SCHEMBL3621188 | 0.75 | MEN1 (0.47) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3622905 | 0.74 | ALDH1A1 (0.43) | NPC1MAPTRAB9ASMN1; SMN2HDAC1 | |
| SCHEMBL3621214 | 0.73 | GSR (0.54) | MAPTSMN1; SMN2 | |
| SCHEMBL3619585 | 0.73 | NR5A2 (0.42) | TP53MAPTSMN1; SMN2 | |
| SCHEMBL3621893 | 0.72 | ALDH1A1 (0.42) | RAB9ASMN1; SMN2ALOX5PTGS2 | |
| SCHEMBL3616927 | 0.72 | ALDH1A1 (0.39) | TP53MAPTSMN1; SMN2ALOX5PTGS2 | |
| SCHEMBL16606313 | 0.71 | HDAC3 (0.47) | VNN1HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL3620680 | 0.70 | KDM4E (0.34) | MAPTSMN1; SMN2ALOX5PTGS2 | |
| SCHEMBL3617344 | 0.70 | NR5A2 (0.49) | NPC1MAPTRAB9ASMN1; SMN2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1517879-A4 | AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME | MERCK & CO INC (US) | 2006-09-13 | — | — | EP | claimed |
| US-20050234265-A1 | Aminoalkylphenols, methods of using and making the same | MERCK SHARP & DOHME LLC | 2005-10-20 | — | — | US | claimed |
| EP-1517879-A1 | AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME | Merck & Co., Inc. (US) | 2005-03-30 | — | — | EP | claimed |
| WO-2004000783-A1 | AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME | MERCK & CO., INC. (US) | 2003-12-31 | — | — | WO | claimed |
| US-7834062-B2 | Aminoalkylphenols, methods of using and making the same | MERCK SHARP & DOHME CORP. (US) | 2010-11-16 | — | — | US | disclosed |
| US-20090298949-A1 | AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME | MERCK SHARP & DOHME LLC | 2009-12-03 | — | — | US | disclosed |
| US-7589127-B2 | Aminoalkylphenols, methods of using and making the same | MERCK & CO., INC. (US) | 2009-09-15 | — | — | US | disclosed |
| EP-1517879-A4 | AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME | MERCK & CO INC (US) | 2006-09-13 | — | — | EP | disclosed |
| US-20050234265-A1 | Aminoalkylphenols, methods of using and making the same | MERCK SHARP & DOHME LLC | 2005-10-20 | — | — | US | disclosed |
| EP-1517879-A1 | AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME | Merck & Co., Inc. (US) | 2005-03-30 | — | — | EP | disclosed |
| WO-2004000783-A1 | AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME | MERCK & CO., INC. (US) | 2003-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090298949-A1 | AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME | NPEPPS, PHOSPHO1, LNPEP | VNN1 1438/4885NPC1 3015/4885TP53 3650/4885 |
| US-20050234265-A1 | Aminoalkylphenols, methods of using and making the same | NPEPPS, PHOSPHO1, LNPEP | VNN1 1438/4885NPC1 3015/4885TP53 3650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.